Updated on 18.08.2026
Sham Foam Limited operates as a manufacturer of PU foam, mattresses, and associated comfort products, serving the domestic market from its centralized production facility in Ambala, Haryana.
The company's BSE SME IPO opens for public subscription on August 11, 2026, and closes on August 13, 2026, aiming to raise up to ₹40.00 crore through a fixed-price fresh issue of 31,14,000 equity shares. Track all the SME IPOs at single place.
The issue price has been fixed at ₹130 per equity share, requiring a minimum retail application of 2,000 shares.
Inside this detailed review of the Sham Foam IPO, we track essential details like the current price band, allotment schedule, subscription data, and today's premium rates.
Briefs of Sham Foam IPO Details
- Price Band: ₹130 per share (Fixed Price)
- IPO Open / Close Dates: 11 August 2026 / 13 August 2026
- Lot Size: 1,000 shares (Minimum retail investment is 2 lots: 2,000 shares)
- Issue Size: 31,14,000 shares / Up to ₹40.00 crores
- Fresh Issue / OFS: Fresh Issue of 31,14,000 shares / OFS: Nil
- Registrar: Alankit Assignments Ltd.
- Listing Exchange: BSE SME
Learn about all these key terms at IPO Glossary: 100+ Important Terms Every Investor Should Know
IPO Reservation
- Face value: ₹10 per share
- Anchor offer: Nil
- QIB-shares: Not applicable (Grouped under Other Investors)
- NIIs-Shares offered: Grouped under Other Investors (Up to 50% of Net Issue)
- RIIs- Shares offered: 14,79,000 Equity Shares (50% of the Net Issue)
How much is Sham Foam's IPO Trading for in Today’s Grey Market?
You can view current and historical grey market premiums for this IPO at our central GMP hub. Because these rates change daily based on informal market demand, they are unofficial and not regulated by SEBI, NSE, or BSE.
More studies GMP vs Listing Gains June 2026 IPOs: A Data Analysis of 22 IPOs
Listing Updates:
| Metric | Value |
|---|---|
| Issue Price | ₹130 |
| Listing Price | ₹104 |
| Listing Gain/Loss | -20.00% |
| Final GMP | ₹1.50 |
| GMP % | 1.15% |
| Lowest GMP | ₹0 |
| Highest GMP | ₹9 |
| GMP vs Listing | Below Expectations |

Sham Foam IPO: Issue Price vs Listing Price.
What are the Key Dates to know Regarding the Sham Foam Allocation Process?
- IPO Open & Close Date: 11 August 2026 to 13 August 2026
- Basis of Allotment Date: 14 August 2026
- Refund Initiation Date: 17 August 2026
- Credit of Shares: 17 August 2026
- Listing Date: 18 August 2026
What are the Primary Objectives behind the Sham Foam IPO Capital Raise?
Capital raised from the new issuance will be allocated by Sham Foam management toward these primary strategic objectives:
- Capital Expenditure: An allocation of ₹14.71 crores is earmarked to expand the existing leased manufacturing plant in Ambala, constructing a new shed and purchasing high-tech machinery.
- Working Capital: A portion of the funds will be directed towards meeting the day-to-day operational requirements and inventory needs.
- General Corporate Purposes: A maximum of 15% of the total gross proceeds, or up to ₹10 crores, will be allocated from the balance to handle everyday operational costs.
How is The Financial Performance of Sham Foam?
A summary of the company’s historical financial performance, presented in Rupees Crores, is detailed below.
Period Ended | 31 Mar 26 | 31 Mar 2025 | 31 Mar 24 |
Total Income | 92.38 | 81.62 | 73.89 |
Profit After Tax | 8.65 | 3.58 | 2.96 |
EBITDA | 10.99 | 4.69 | 4.43 |
Total Borrowing | 3.99 | 9.21 | 10.10 |
Assets | 49.32 | 36.58 | 33.54 |
Financial Observations
Total Income
The company registered a consistent and steady expansion in its top-line revenue over the last three fiscal years.
- Total income scaled from ₹73.89 crores in FY24 to ₹92.38 crores in FY26.
- This progression reflects a strong domestic market surge for PU foam and comfort products.
- Centralised manufacturing efficiently supported the execution of growing domestic orders.

Profit After Tax
Net profitability experienced exceptional multi-fold growth as operational capabilities matured.
- PAT surged remarkably from ₹2.96 crores in FY24 to ₹8.65 crores in FY26.
- The PAT margin improved noticeably, hitting 9.37% in the latest fiscal year.
- Lower proportionate raw material costs contributed heavily to this bottom-line momentum.

EBITDA
Core operational earnings advanced significantly, highlighting the firm's improved manufacturing efficiencies.
- EBITDA more than doubled from ₹4.43 crores in FY24 to ₹10.99 crores in FY26.
- The EBITDA margin expanded rapidly to 11.91% during the most recent fiscal period.
- Operating leverage improved significantly as production volumes scaled up.

Total Borrowing
The business successfully executed an aggressive debt-repayment strategy prior to its IPO.
- Total borrowings decreased significantly from ₹10.10 crores in FY24 to just ₹3.99 crores in FY26.
- This deleveraging de-risked the balance sheet, bringing the debt-to-equity ratio down to 0.19x.
- A cleaner balance sheet allows future cash flows to be directed entirely towards growth.

Assets
The overall resource base of the company widened to accommodate its rising inventory and trade receivables.
- Total assets grew from ₹33.54 crores in FY24 to ₹49.32 crores in FY26.
- This build-up is tied to a lengthening working capital cycle necessary for scaling domestic sales.
- The upcoming IPO-funded capital expenditure will further expand the physical asset base post-listing.
What Are the P/E ratio and Peer Comparison of Sham Foam Limited?
At the designated offer price of ₹130 per share, Sham Foam Limited trades at a P/E ratio of 12.58x relative to its reported FY26 earnings per share of 10.33.
Also check IPO Valuation vs Listing Performance Study 2026
Name of the Company | Total Revenue (₹ Cr) | Face Value (₹) | Basic EPS (₹) | P/E Ratio | RoNW (%) | NAV (₹) |
Sham Foam Limited | 92.31 | 10 | 10.33 | 12.58 | 40.97 | 25.21 |
Sheela Foam Limited | 2,962.27 | 5 | 11.96 | 64.50 | 4.48 | 266.69 |
Wakefit Innovations Ltd | 1,488.94 | 1 | 6.03 | 21.22 | 22.90 | 343.00 |
Analysis:
Sham Foam Limited enters the primary market at an implied P/E multiple of 12.58x based on its fixed issue price of ₹130.
When evaluated against listed industry peers like Wakefit Innovations (21.22x) and sector giant Sheela Foam (64.50x), the issue is priced at a steep discount.
While Sham Foam operates on a much smaller absolute revenue base (₹92.31 crores in FY26), it commands an exceptionally superior Return on Net Worth (RoNW) of 40.97%, heavily outpacing Sheela Foam (4.48%) and Wakefit (22.90%).
This indicates highly efficient capital utilisation and robust operational profitability within its specific niche scale.
What is The Industry Outlook of Sham Foam Limited?
Growth potential
- The Indian mattress and PU foam industry is experiencing rapid expansion, driven by rising disposable incomes, urbanisation, and a growing consumer focus on health and sleep quality.
- A distinct shift from the unorganised sector—which historically dominated the market with cotton fillers—towards organised branded players offering scientifically designed foam and spring mattresses presents a massive runway for volume growth.
- The booming real estate sector and the resurgence of the hospitality industry are driving institutional demand for bulk comfort products.
Market trends
- The industry is highly dependent on raw material inputs like polyols and TDI (Toluene Di-Isocyanate), making manufacturers susceptible to international petrochemical price fluctuations.
- Companies are increasingly adopting direct-to-consumer (D2C) channels and e-commerce platforms to bypass traditional multi-tiered distribution networks, thereby protecting operating margins.
- Centralised, highly automated manufacturing facilities are becoming essential to ensure product consistency, minimise scrap rates, and manage the bulky logistics of shipping foam products across domestic markets.
What Are The Strengths and Potential Risks of Sham Foam IPO ?
Strengths:
- Margin Expansion: EBITDA margins nearly doubled to 11.91% in FY26, primarily driven by a decrease in the proportionate cost of raw materials.
- Superior Return Metrics: The business achieved a 51.53% Return on Equity (RoE) and a 40.97% Return on Net Worth (RoNW) in FY26, reflecting highly efficient capital usage compared to listed peers.
- Substantial Deleveraging: The company aggressively reduced long-term borrowings from ₹9.76 crores in FY24 to ₹3.71 crores in FY26, bringing the pre-issue Debt-to-Equity ratio down to a highly conservative 0.19x.
Risks:
- Centralised Facility Risk: The company operates entirely out of a single leased manufacturing facility in Rajpura, Haryana. Failure to renew this lease would severely halt business operations.
- Working Capital Strain: Inventory holding levels rose to 44 days (FY26), while Trade Receivable recovery lengthened to 93 days, locking up a growing portion of cash in daily operations.
- Creditor Dependency: As of March 2026, the company holds significant outstanding dues to creditors, including ₹17.06 crores owed to 5 material creditors, posing supply chain dependencies.
Important iPO Resources
1. Upcoming & Live IPOs in India
2. IPO Allotment Status – How to Check Allotment Status of IPO Shares
3. Latest IPO Subscription Status Today
5. July 2026 IPO Review: 33 IPOs, ₹21140.52 Cr Raised & 56.37x Average Subscription
6. July 2026 IPO Subscription Review: 32 IPOs Data, Demand Patterns & Key Trends
Key Considerations for Investors
- Valuation Discount: At the fixed issue price of ₹130, the company demands an implied P/E of 12.58x, offering a steep valuation discount compared to peers like Wakefit (21.22x) and Sheela Foam (64.50x).
- Operational Risk: Operations are entirely concentrated at a single, leased manufacturing facility in Haryana; any lease disruption poses a severe continuity threat.
- Working Capital Stretching: Trade receivable recovery days have lengthened to 93 days, tying up significant cash and indicating pressure on client payment cycles.
- Deleveraged Balance Sheet: A massive pre-IPO debt reduction strategy lowered total borrowings to just ₹3.99 crores in FY26, providing the firm with a highly conservative and clean capital structure.
Key Takeaways
- IPO Price Band: ₹130 per equity share (Fixed Price)
- Lot Size: 1,000 shares (Minimum retail application of ₹2,60,000 for 2 lots)
- Allotment Date: Allotment on 14 August 2026;
- Listing Dates: Listing on BSE SME on 18 August 2026
FAQs on Sham Foam IPO
What is the current grey market premium (GMP) for the Sham Foam IPO?
Follow the daily changes in grey market premium for this SME IPO by visiting our specialized GMP tracking page. These informal premium levels vary each day according to shifts in broader market sentiment.
What is the officially established price band for the Sham Foam IPO?
Shares for this public issue are priced at a fixed rate of ₹130 each.
What is the key calendar date for the Sham Foam share allocation process?
Investors can expect the final share allocation schedule to be locked in on August 14, 2026.
What is the procedure for verifying an investor's share allocation status for the Sham Foam IPO?
When the process concludes, you can view your official allotment outcome on the Alankit Assignments portal by providing your application reference or PAN.
What is Sham Foam IPO listing date?
Sham Foam proposes to list its equity shares on the BSE SME segment on August 18, 2026.
Investment Perspective on Sham Foam IPO
Sham Foam’s IPO at Rs 130 offers a highly compelling value proposition. Priced at a modest 12.58x FY26 P/E, it stands at a deep discount compared to listed peers Sheela Foam (64.50x) and Wakefit (21.22x).
While its PAT grew to Rs 865.06 Lakhs, investors must weigh this robust growth against severe single facility concentration risks in its sole Ambala manufacturing unit.
Potential investors should base their decisions on a thorough reading of the prospectus, noting the company's single-facility dependency, extended receivable days, and aggressive debt reduction.
Disclaimer: The details above serve as a general educational guide rather than formal financial recommendations. We advise individuals to verify their investment strategies with a certified SEBI specialist before committing capital.
